REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Liget Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Liget Pharma Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

Liget Pharma Kft. is an enterprise in Hungary, with the main office in Debrecen. The enterprise operates in the Pharmacies and Drug Stores industry. It was incorporated on June 20, 2022. 8 (2024) employees currently work for Liget Pharma Kft.. From the latest financial highlights, Liget Pharma Kft. reported a net sales revenue increase of 23.14% in 2024. Over the same period, its total assets grew by 1.34%. In 2024, Liget Pharma Kft.’s net profit margin increased by 1.05%.

Headquarters
Kishatar utca 7 U5-U6.
Debrecen; Hajdu-Bihar; Postal Code: 4031

Contact Details: Purchase the Liget Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Liget Pharma Kft. report to view the information.
Registered Capital:
Purchase the Liget Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Liget Pharma Kft. report to view the information.
Incorporation Date:
June 20, 2022
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Liget Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
23.14%▲
Total operating revenue
22.86%▲
Operating profit (EBIT)
32.13%▲
EBITDA
31.99%▲
Net Profit (Loss) for the Period
32.7%▲
Total Assets
1.34%▲
Total Equity
32.17%▲
Operating Profit Margin (ROS)
1.08%▲
Net Profit Margin
1.05%▲
Return on Equity (ROE)
0.37%▲
Quick Ratio
0.82%▲
Cash Ratio
0.76%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo